| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.077 | 0.2 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |